Later, the structure–activity relationship (SAR) study of 4-phenoxy-phenyl isoxazoles was performed with the belief that these new chemical entities would effectively target the ACC enzyme and provide a new approach for cancer treatment. This evidence concerns the gene ACACA and cancer.